Skip to main content
AAN.com

Abstract

Background:

Antibodies against voltage-gated potassium channel (VGKC)–complex are implicated in the pathogenesis of acquired neuromyotonia, limbic encephalitis, faciobrachial dystonic seizure, and Morvan syndrome. Outside these entities, the clinical value of VGKC-complex antibodies remains unclear.

Methods:

We conducted a single-center review of patients positive for VGKC-complex antibodies over an 8-year period.

Results:

Among 114 patients positive for VGKC-complex antibody, 11 (9.6%) carrying the diagnosis of limbic encephalitis (n = 9) or neuromyotonia (n = 2) constituted the classic group, and the remaining 103 cases of various neurologic and non-neurologic disorders comprised the nonclassic group. The median titer for the classic group was higher than the nonclassic group (p < 0.0001). A total of 90.9% of the patients in the classic and 21.4% in the nonclassic group possessed high (>0.25 nM) VGKC-complex antibody levels (p < 0.0001). A total of 75.0% of the patients in the high-level group had definite or probable autoimmune basis, while nonautoimmune disorders were seen in 75.6% of patients from the low-level group (p < 0.0001). A total of 26.3% of patients were found with active or remote solid organ or hematologic malignancy, but no antibody titer difference was observed among subgroups of absent, active, or remote malignancy. Compared to age-matched US national census, rates of active cancer in our cohort were higher in patients older than 45 years.

Conclusions:

High VGKC-complex antibody titers are more likely found in patients with classically associated syndromes and other autoimmune conditions. Low-level VGKC-complex antibodies can be detected in nonspecific and mostly nonautoimmune disorders. The presence of VGKC-complex antibody, rather than its level, may serve as a marker of malignancy.

Get full access to this article

View all available purchase options and get full access to this article.

REFERENCES

1.
Hart IK, Waters C, Vincent A, et al. Autoantibodies detected to expressed K+ channels are implicated in neuromyotonia. Ann Neurol 1997;41:238–246.
2.
Barber P, Anderson N, Vincent A. Morvan's syndrome associated with voltage-gated K+ channel antibodies. Neurology 2000;54:771–772.
3.
Buckley C, Oger J, Clover L, et al. Potassium channel antibodies in two patients with reversible limbic encephalitis. Ann Neurol 2001;50:73–78.
4.
Irani SR, Michell AW, Lang B, et al. Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis. Ann Neurol 2011;69:892–900.
5.
Irani SR, Alexander S, Waters P, et al. Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia. Brain 2010;133:2734–2748.
6.
Knowles CH, Lang B, Clover L, et al. A role for autoantibodies in some cases of acquired nonparaneoplastic gut dysmotility. Scand J Gastroenterol 2002;37:166–170.
7.
Majoie HJ, de Baets M, Renier W, Lang B, Vincent A. Antibodies to voltage-gated potassium and calcium channels in epilepsy. Epilepsy Res 2006;71:135–141.
8.
Tan KM, Lennon VA, Klein CJ, Boeve BF, Pittock SJ. Clinical spectrum of voltage-gated potassium channel autoimmunity. Neurology 2008;70:1883–1890.
9.
Paterson RW, Zandi MS, Armstrong R, Vincent A, Schott JM. Clinical relevance of positive voltage-gated potassium channel (VGKC)-complex antibodies: experience from a tertiary referral centre. J Neurol Neurosurg Psychiatry 2014;85:625–630.
10.
Huda S, Wong SH, Pettingill P, O'Connell D, Vincent A, Steiger M. An 11-year retrospective experience of antibodies against the voltage-gated potassium channel (VGKC) complex from a tertiary neurological centre. J Neurol 2015;262:418–424.
11.
American Cancer Society, Surveillance Research 2010 [online]. Available at: http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-026089.pdf. Accessed February 15, 2016.
12.
Howden LM, Meyer JA. Age and sex composition: 2010 census briefs. In: United States Census Bureau [online]. Available at: http://www.census.gov/prod/cen2010/briefs/c2010br-03.pdf. Accessed February 15, 2016.
13.
Isaacs H. A syndrome of continuous muscle fibre activity. J Neurol Neurosurg Psychiatry 1961;24:319–325.
14.
Corsellis JAN, Goldberg GJ, Norton RA. Limbic encephalitis and its associations with carcinoma. Brain 1968;91:481–496.
15.
Vincent A, Bien CG, Irani SR, Waters P. Autoantibodies associated with diseases of the CNS: new developments and future challenges. Lancet Neurol 2011;10:759–772.
16.
Olberg H, Haugen M, Storstein A, Vedeler CA. Neurological manifestations related to level of voltage-gated potassium channel antibodies. J Neurol Neurosurg Psychiatry 2013;84:941–943.
17.
Hacohen Y, Singh R, Rossi M, et al. Clinical relevance of voltage-gated potassium channel–complex antibodies in children. Neurology 2015;85:967–975.
18.
Klein CJ, Lennon VA, Aston PA, et al. Insights from LGI1 and CASPR2 potassium channel complex autoantibody subtyping. JAMA Neurol 2013;70:229–234.
19.
Vincent A, Buckley C, Schott JM, et al. Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. Brain 2004;127:701–712.
20.
Vernino S, Lennon VA. Ion channel and striational antibodies define a continuum of autoimmune neuromuscular hyperexcitability. Muscle Nerve 2002;26:702–707.
21.
Dahm L, Ott C, Steiner J, et al. Seroprevalence of autoantibodies against brain antigens in health and disease. Ann Neurol 2014;76:82–94.
22.
Li Y, Jammoul A, Mente K, et al. Clinical experience of seropositive ganglionic acetylcholine receptor antibody in a tertiary neurology referral center. Muscle Nerve 2015;52:386–391.

Information & Authors

Information

Published In

Neurology® Clinical Practice
Volume 6Number 5October 2016
Pages: 409-418

Publication History

Received: November 13, 2015
Accepted: March 9, 2016
Published online: June 29, 2016
Published in print: October 2016

Permissions

Request permissions for this article.

Disclosures

A. Jammoul, L. Shayya, K. Mente, and J. Li report no disclosures. A.D. Rae-Grant serves on the Evidence Review Team for Neurology®; receives publishing royalties for Handbook of Multiple Sclerosis (Springer Healthcare, 2010), Comprehensive Review of Clinical Neurology (Wolters Kluwer, 2012), and 5 Minute Consult in Neurology (Wolters Kluwer, 2012); received payment for editing neurology chapters for Dynamic Medical, an online textbook funded via library subscriptions; and receives research support from NIH and National MS Society. Y. Li reports no disclosures. Full disclosure form information provided by the authors is available with the full text of this article at Neurology.org/cp.

Study Funding

No targeted funding reported.

Authors

Affiliations & Disclosures

Adham Jammoul, MD
Neurohospitalist Program (AJ), Aultman Hospital, Canton; and Department of Neurology (LS, KM, AR-G, YL) and Department of Quantitative Health Sciences, Lerner Research Institute (JL), Cleveland Clinic Foundation, OH.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Luay Shayya, MD
Neurohospitalist Program (AJ), Aultman Hospital, Canton; and Department of Neurology (LS, KM, AR-G, YL) and Department of Quantitative Health Sciences, Lerner Research Institute (JL), Cleveland Clinic Foundation, OH.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Karin Mente, MD
Neurohospitalist Program (AJ), Aultman Hospital, Canton; and Department of Neurology (LS, KM, AR-G, YL) and Department of Quantitative Health Sciences, Lerner Research Institute (JL), Cleveland Clinic Foundation, OH.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Jianbo Li, PhD
Neurohospitalist Program (AJ), Aultman Hospital, Canton; and Department of Neurology (LS, KM, AR-G, YL) and Department of Quantitative Health Sciences, Lerner Research Institute (JL), Cleveland Clinic Foundation, OH.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Alexander Rae-Grant, MD
Neurohospitalist Program (AJ), Aultman Hospital, Canton; and Department of Neurology (LS, KM, AR-G, YL) and Department of Quantitative Health Sciences, Lerner Research Institute (JL), Cleveland Clinic Foundation, OH.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Yuebing Li, MD, PhD
Neurohospitalist Program (AJ), Aultman Hospital, Canton; and Department of Neurology (LS, KM, AR-G, YL) and Department of Quantitative Health Sciences, Lerner Research Institute (JL), Cleveland Clinic Foundation, OH.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE

Notes

Correspondence to: [email protected]
Funding information and disclosures are provided at the end of the article. Full disclosure form information provided by the authors is available with the full text of this article at Neurology.org/cp.

Author Contributions

Adham Jammoul, Luay Shayya, and Karin Mente: acquisition and analysis of data. Jianbo Li: analysis of data. Alexander Rae-Grant: study concept and design, critical revision of the manuscript. Yuebing Li: study concept and design, acquisition and analysis of data, critical revision of the manuscript.

Metrics & Citations

Metrics

Citation information is sourced from Crossref Cited-by service.

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By
  1. Anti-N-Methyl-D-Aspartate (NMDA) Receptor Encephalitis Secondary to an Ovarian Dermoid Cyst, Cureus, (2024).https://doi.org/10.7759/cureus.67193
    Crossref
  2. Mercury Induced Autoimmunity: A Case of CASPR2/LGI1 Autoimmune Encephalitis in a 14-Month-old, Child Neurology Open, 11, (2024).https://doi.org/10.1177/2329048X241227347
    Crossref
  3. Dramatic Hyperhidrosis, Labile Blood Pressure, and Fever Associated With Thymoma, The American Journal of Medicine, 137, 10, (949-950), (2024).https://doi.org/10.1016/j.amjmed.2024.05.012
    Crossref
  4. Occult bowel cancer presenting as Morvan syndrome, BMJ Case Reports, 16, 11, (e256407), (2023).https://doi.org/10.1136/bcr-2023-256407
    Crossref
  5. Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Ninth Special Issue, Journal of Clinical Apheresis, 38, 2, (77-278), (2023).https://doi.org/10.1002/jca.22043
    Crossref
  6. Utilidad de los anticuerpos en las enfermedades de la unión neuromuscular: revisión, Neurología Argentina, 14, 1, (37-50), (2022).https://doi.org/10.1016/j.neuarg.2021.08.004
    Crossref
  7. Autoimmune Limbic Encephalitis: A Review of Clinicoradiological Features and the Challenges of Diagnosis, Cureus, (2021).https://doi.org/10.7759/cureus.17529
    Crossref
  8. Voltage-gated potassium channel blanket testing in first-episode psychosis: Diagnostic nihilism?, Australian & New Zealand Journal of Psychiatry, 55, 8, (817-823), (2021).https://doi.org/10.1177/0004867420983454
    Crossref
  9. Autoimmune encephalitis: proposed recommendations for symptomatic and long-term management, Journal of Neurology, Neurosurgery & Psychiatry, 92, 8, (897-907), (2021).https://doi.org/10.1136/jnnp-2020-325302
    Crossref
  10. Evaluating the frequency of positive paraneoplastic antibodies and associated malignancy risk, Journal of the Neurological Sciences, 423, (117347), (2021).https://doi.org/10.1016/j.jns.2021.117347
    Crossref
  11. See more
Loading...

View Options

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.

If you need immediate support or to place an order, please call or email customer service:

  • 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
  • 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
  • [email protected]

We appreciate your patience during this time and apologize for any inconvenience.

View options

PDF and All Supplements

Download PDF and Supplementary Material

Full Text

View Full Text

Full Text HTML

View Full Text HTML

Media

Figures

Other

Tables

Share

Share

Share article link

Share